ghk cu clinical trials results january 2026 GHK-Cu Copper Tripeptide-1 Peptide – Peptagon CRISPR Clinical Trials: A 2026

Applying strong actives after skin procedures without guidance can raise the risk of irritation or infection

Naturally sourced from the Onsen-Sui springs in France, its known for its soothing, hydrating, and balancing properties that help support skin comfort, barrier strength, and ingredient performance

This powder format is suitable for formulators who need a high-concentration Copper Tripeptide-1 active and want full control over the finished serum, gel, lotion, cream, or professional-care formula

This chelation is critical: it effectively silences the metals free redox activity, preventing oxidative damage from unbound copper ions while maintaining bioavailability

Light exposure represents a significant degradation pathway, with UV and visible light catalyzing oxidative damage to the peptide backbone and disruption of copper coordination